Advertisement
Posters GI/NUTRITION| Volume 21, SUPPLEMENT 2, S112, October 2022

191 Cystic fibrosis transmembrane conductance regulator potentiator (ivacaftor) has minimal effects on gut microbiome composition in people with cystic fibrosis and gating mutations

DOI:https://doi.org/10.1016/S1569-1993(22)00881-5
191 Cystic fibrosis transmembrane conductance regulator potentiator (ivacaftor) has minimal effects on gut microbiome composition in people with cystic fibrosis and gating mutations
Previous Article190 Hyperosmolar salt concentrations slow digestion of milk and meconium by pancreatic enzymes
Next Article192 Gastrointestinal symptoms in a cystic fibrosis transmembrane conductance regulator modulator era—an international survey
      This paper is only available as a PDF. To read, Please Download here.

      Article info

      Identification

      DOI: https://doi.org/10.1016/S1569-1993(22)00881-5

      Copyright

      © 2022 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX